Published in Heart on November 01, 2004
Heart failure-induced changes of voltage-gated Ca2+ channels and cell excitability in rat cardiac postganglionic neurons. Am J Physiol Cell Physiol (2013) 1.44
The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat (2010) 1.06
Neurocardiological differences between musicians and control subjects. Neth Heart J (2013) 1.06
Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol (2013) 1.02
Electrophysiological and neuroanatomical evidence of sexual dimorphism in aortic baroreceptor and vagal afferents in rat. Am J Physiol Regul Integr Comp Physiol (2008) 0.97
The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. Am J Physiol Regul Integr Comp Physiol (2008) 0.95
Absence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia. Circ Arrhythm Electrophysiol (2010) 0.90
Cardiac autonomic functions derived from short-term heart rate variability recordings associated with heart rate recovery after treadmill exercise test in young individuals. Heart Vessels (2010) 0.88
Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats. J Neurosci Res (2010) 0.86
Impaired baroreflex function in temporal lobe epilepsy. J Neurol (2006) 0.86
In vivo transfection of manganese superoxide dismutase gene or nuclear factor κB shRNA in nodose ganglia improves aortic baroreceptor function in heart failure rats. Hypertension (2013) 0.79
Effect of angiotensin II on voltage-gated sodium currents in aortic baroreceptor neurons and arterial baroreflex sensitivity in heart failure rats. J Hypertens (2015) 0.78
Prognostic Value of Heart Rate Variability in Patients With Cancer. J Clin Neurophysiol (2015) 0.78
Angiotensin II-superoxide-NFκB signaling and aortic baroreceptor dysfunction in chronic heart failure. Front Neurosci (2015) 0.77
[Psychosomatic aspects of chronic heart failure. Nothing but depression?]. Herz (2011) 0.76
Heart-Rate Variability-More than Heart Beats? Front Public Health (2017) 0.76
Parasympathetic reactivation in children: influence of two various modes of exercise. Clin Auton Res (2015) 0.75
Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep (2016) 0.75
Correlation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial Infarction. Front Neurosci (2017) 0.75
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation (1996) 37.54
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10
Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res (1969) 5.27
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation (1998) 3.99
Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation (2000) 3.94
Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation (2003) 3.75
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci (Lond) (1995) 2.92
Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol (1994) 2.89
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol (2001) 2.04
Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension (1995) 2.04
Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation (1997) 2.03
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation (1988) 1.99
Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension (1987) 1.96
Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension (1988) 1.90
The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation (1993) 1.73
Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation (1988) 1.67
Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol (1979) 1.64
Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation (1990) 1.63
Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol (1995) 1.63
Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation (1989) 1.60
Aldosterone blunts the baroreflex response in man. Clin Sci (Lond) (1998) 1.60
Aldosterone reduces baroreceptor discharge in the dog. Hypertension (1992) 1.54
Measuring baroreflex sensitivity from the gain function between arterial pressure and heart period. Clin Sci (Lond) (2002) 1.53
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol (2002) 1.47
Comparison between invasive and non-invasive measurements of baroreflex sensitivity; implications for studies on risk stratification after a myocardial infarction. Eur Heart J (2000) 1.43
Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation (1997) 1.29
Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation (1989) 1.28
Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res (1997) 1.24
Chaos theory, heart rate variability, and arrhythmic mortality. Circulation (2000) 1.23
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol (2002) 1.20
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol (1993) 1.18
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol (2000) 1.15
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol (1993) 1.09
Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure. Clin Sci (Lond) (1999) 1.06
Opposing central and peripheral effects of atropine on parasympathetic cardiac control. Am J Physiol (1977) 1.03
Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J (1992) 1.03
Blunted arterial baroreflex causes "pathological" heart rate turbulence. Am J Physiol Regul Integr Comp Physiol (2000) 1.03
Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res (1990) 1.01
Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation (1994) 0.97
Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation (1994) 0.95
Pitfalls in the interpretation of spectral analysis of the heart rate variability during exercise in humans. Acta Physiol Scand (1995) 0.94
Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol (1996) 0.94
Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol (1995) 0.91
Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol (1992) 0.87
Effect of exogenous nitric oxide on baroreflex function in humans. Am J Physiol (1999) 0.86
Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study. Am Heart J (1999) 0.85
Temporally localized contributions to measures of large-scale heart rate variability. Am J Physiol (1998) 0.84
Applicability of new techniques in the assessment of arterial baroreflex sensitivity in the elderly: a comparison with established pharmacological methods. Clin Sci (Lond) (1998) 0.83
Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure. Clin Sci (Lond) (2001) 0.82
Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart (1996) 0.82
Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction. Am J Cardiol (1993) 0.81
Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail (2002) 0.81
Effect of beta-blockade on baroreceptor and autonomic function in heart failure. Clin Sci (Lond) (1999) 0.81
Intravertebral angiotensin II inhibits cardiac vagal efferent activity in dogs. Neuroendocrinology (1985) 0.77
Determinants of heart rate variability in heart transplanted subjects during physical exercise. Eur Heart J (1996) 0.76